Setty M Magaña1,2, Timothy E Peterson1, Jared E Evans1, Paul A Decker1, Vernadette Simon1, Jeanette E Eckel-Passow1, David J Daniels1, Ian F Parney3. 1. Departments of Neurology (SMM), Neurologic Surgery (TEP, DJD, IFP), Health Sciences Research (JEE, PAD, JEEP), Medical Genome Analysis Core (VS); Immunology (IFP), Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA. 2. Department of Pediatrics, Nationwide Children's Hospital, Columbus, OH, USA. 3. Departments of Neurology (SMM), Neurologic Surgery (TEP, DJD, IFP), Health Sciences Research (JEE, PAD, JEEP), Medical Genome Analysis Core (VS); Immunology (IFP), Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA. Parney.Ian@mayo.edu.
Abstract
BACKGROUND: Medulloblastoma (MB) and diffuse infiltrative pontine glioma (DIPG) are malignant pediatric tumors. Extracellular vesicles (EVs) and their bioactive cargoes have been implicated in tumorigenesis. Most studies have focused on adult tumors, therefore the role of EVs and the noncoding RNA (ncRNA) landscape in pediatric brain tumors is not fully characterized. The overall aim of this pilot study was to isolate EVs from MB and DIPG patient-derived cell lines and to explore the small ncRNA transcriptome. METHODS: EVs from 3 DIPG and 4 MB patient-derived cell lines were analyzed. High-throughput next generation sequencing interrogated the short non-coding RNA (ncRNA) transcriptome. Known and novel miRNAs were quantified. Differential expression analysis, in silico target prediction, and functional gene enrichment were performed. RESULTS: EV secretomes from MB and DIPG patient-derived cell lines demonstrated discrete ncRNA biotypes. Notably, miRNAs were depleted and Y RNAs were enriched in EV samples. Hierarchical cluster analysis revealed high discrimination in miRNA expression between DIPG and MB cell lines and RNA-Seq identified novel miRNAs not previously implicated in MB or DIPG pathogenesis. Known and putative target genes of dysregulated miRNAs were identified. Functional annotation analysis of the target genes for differentially expressed EV-and parental-derived miRNAs revealed significant cancer-related pathway involvement. CONCLUSIONS: This hypothesis-generating study demonstrated that pediatric brain tumor-derived cell lines secrete EVs comprised of various ncRNA cargoes. Validation of these findings in patient samples may provide new insights into the pediatric brain tumor microenvironment and identification of novel therapeutic candidates.
BACKGROUND: Medulloblastoma (MB) and diffuse infiltrative pontine glioma (DIPG) are malignant pediatric tumors. Extracellular vesicles (EVs) and their bioactive cargoes have been implicated in tumorigenesis. Most studies have focused on adult tumors, therefore the role of EVs and the noncoding RNA (ncRNA) landscape in pediatric brain tumors is not fully characterized. The overall aim of this pilot study was to isolate EVs from MB and DIPG patient-derived cell lines and to explore the small ncRNA transcriptome. METHODS: EVs from 3 DIPG and 4 MB patient-derived cell lines were analyzed. High-throughput next generation sequencing interrogated the short non-coding RNA (ncRNA) transcriptome. Known and novel miRNAs were quantified. Differential expression analysis, in silico target prediction, and functional gene enrichment were performed. RESULTS: EV secretomes from MB and DIPG patient-derived cell lines demonstrated discrete ncRNA biotypes. Notably, miRNAs were depleted and Y RNAs were enriched in EV samples. Hierarchical cluster analysis revealed high discrimination in miRNA expression between DIPG and MB cell lines and RNA-Seq identified novel miRNAs not previously implicated in MB or DIPG pathogenesis. Known and putative target genes of dysregulated miRNAs were identified. Functional annotation analysis of the target genes for differentially expressed EV-and parental-derived miRNAs revealed significant cancer-related pathway involvement. CONCLUSIONS: This hypothesis-generating study demonstrated that pediatric brain tumor-derived cell lines secrete EVs comprised of various ncRNA cargoes. Validation of these findings in patient samples may provide new insights into the pediatric brain tumor microenvironment and identification of novel therapeutic candidates.
Authors: Jakub Godlewski; Anna M Krichevsky; Mark D Johnson; E Antonio Chiocca; Agnieszka Bronisz Journal: Neuro Oncol Date: 2014-10-09 Impact factor: 12.300
Authors: Esther N M Nolte-'t Hoen; Henk P J Buermans; Maaike Waasdorp; Willem Stoorvogel; Marca H M Wauben; Peter A C 't Hoen Journal: Nucleic Acids Res Date: 2012-07-19 Impact factor: 16.971
Authors: Volker Hovestadt; Olivier Ayrault; Fredrik J Swartling; Giles W Robinson; Stefan M Pfister; Paul A Northcott Journal: Nat Rev Cancer Date: 2019-12-09 Impact factor: 69.800
Authors: Cheryl C Y Li; Sally A Eaton; Paul E Young; Maggie Lee; Rupert Shuttleworth; David T Humphreys; Georges E Grau; Valery Combes; Mary Bebawy; Joyce Gong; Susan Brammah; Michael E Buckland; Catherine M Suter Journal: RNA Biol Date: 2013-06-17 Impact factor: 4.652
Authors: Linda Cambier; Geoffrey de Couto; Ahmed Ibrahim; Antonio K Echavez; Jackelyn Valle; Weixin Liu; Michelle Kreke; Rachel R Smith; Linda Marbán; Eduardo Marbán Journal: EMBO Mol Med Date: 2017-03 Impact factor: 12.137
Authors: John P Welby; Tatiana Kaptzan; Anton Wohl; Timothy E Peterson; Aditya Raghunathan; Desmond A Brown; Shiv K Gupta; Liang Zhang; David J Daniels Journal: Front Oncol Date: 2019-02-27 Impact factor: 6.244
Authors: Zhiyun Wei; Arsen O Batagov; Sergio Schinelli; Jintu Wang; Yang Wang; Rachid El Fatimy; Rosalia Rabinovsky; Leonora Balaj; Clark C Chen; Fred Hochberg; Bob Carter; Xandra O Breakefield; Anna M Krichevsky Journal: Nat Commun Date: 2017-10-26 Impact factor: 14.919